FDA Approves the First New Cystic Fibrosis Treatment in Decades
The drug, Trikafta, which was developed by Vertex Pharmaceuticals, can be used to treat 90% of cystic fibrosis patients 12 years or older in America.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
